World of DTC Marketing
AUGUST 12, 2022
Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The most telling data on a disconnect between drug prices and research costs has received almost no public attention.
European Pharmaceutical Review
OCTOBER 23, 2023
1 In pharmaceutical manufacturing, the high level of final product quality is the major driver. Tablets should be defect-free and compliant to good manufacturing practice (GMP) aspects and final-user requirements. Pharmaceutical Technology. Fixing Tableting Problems. International Journal of Food Properties.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 28, 2022
In particular, the area’s unique charm enables it to attract young, college-educated workers, with USA Today dubbing Charleston a ‘millennial magnet’ in 2014 due to its high ratio of millennials to teens. Many companies have their eyes on Charleston right now, as the location performs highly across all of the trending FDI drivers.
European Pharmaceutical Review
OCTOBER 20, 2022
Her current research is focused on spectroscopy and mathematical modelling as process analytical technologies in pharmaceutical manufacturing. Inspection Technical Guide – Water for Pharmaceutical Use. The research is focused on multiple processes, such as cleaning verification and formulation of drug products. References.
pharmaphorum
OCTOBER 26, 2022
The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner.
Pharmaceutical Technology
APRIL 18, 2023
The new facilities will also support the company’s efforts to manufacture new therapeutic modalities, including genetic medicines. The company has launched 19 new medicines since 2014, including Jaypirca, which was approved by the US Food and Drug Administration in January 2023 to treat mantle cell lymphoma.
pharmaphorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. ” Image from the Association of the British Pharmaceutical Industry (ABPI).
Expert insights. Personalized for you.
255 
Let's personalize your content